Blood and Blood components / Projects

First Programme of Community action in the field of public health (2003-2008)
Creating a safe and sufficient donor population in Europe: comparing and recommending good donor management practice [DOMAINE]
The project aims to achieve a safe and sufficient blood supply for all European citizens by establishing Good Donor Management practice in all Member States.
Start date: 01/03/2008 - End date: 01/07/2011

Call: Responding To Health Threats Rapidly And In A Co-Ordinated Manner (Ht 2007)
Topic: Blood and Blood components
3rd Health Programme (2014-2020)
Good Practices for demonstrating safety and quality through recipient follow-up [Euro-GTP II]
The main objective of this project is to set up the good practices applied to tissues and cells (T&C) preparation processes and patient follow-up procedures, to ensure their safe and effective impleme...
The main objective of this project is to set up the good practices applied to tissues and cells (T&C) preparation processes and patient follow-up procedures, to ensure their safe and effective implementation.
The outputs of this project will provide tools for assessing and verifying the quality, promote safety and assure efficacy of therapies with human tissues, Hematopoietic Stem Cells (HSC) and Assisted Reproductive Technologies (ART), addressing mainly to the implementation of novel T&C preparation processes and clinical indications, but also to the need of retrospective studies where weaknesses or insufficient safety data currently exist.
Recommendations will be forwarded to Tissue Establishments (TE) and Organizations Responsible for Human Application (ORHA), as the main actors in the process of validation and designing T&C preparation processes and patient follow-up according to a clinical indication.
This project aim to define the threshold of novelty, including definition of the factors that should be considered to determine the scope and depth of the clinical follow-up studies needed. The scope and extent of the recommended studies will be determined on the basis of a risk based approach performed taking into account factors such as the novelty of the product/preparation process/clinical indication, and its technical complexity.
A T&C Database of products, preparation procedures, clinical applications and their current status of authorisation and implementation will be established, working as a starting point for determining the ‘novelty’ of processes/therapies by TEs and ORHAs, and allowing the use of established processes/therapies by any centre that strictly follows the same procedure/clinical procedure/indication.
This project also aims to define a “GTP’s management model” that could provide impetus for future standards harmonisation and promotion, and allow the establishment of European accreditation and training programs for TE.
Start date: 01/04/2016 - End date: 31/03/2019

Call: Call for Proposals for Projects 2015
Topic: Blood and Blood components
First Programme of Community action in the field of public health (2003-2008)
EU Optimal Blood Use Project [EUOBUP]
This project will encourage best European practice on the optimal use of blood components and therapeutic practice.
Start date: 01/05/2007 - End date: 01/05/2010

Call: Responding Rapidly And In A Co-Ordinated Fashion To Health Threats (Ht 2006)
Topic: Blood and Blood components